Insulin is a peptide hormone produced by the pancreas and is central to regulating carbohydrate and fat metabolism in the body. Insulin therapy is used for the treatment of people with type 1 diabetes in order to avoid complications arising from hyperglycemia. Insulin is administered mainly through subcutaneous insulin injections such as vials and syringes, insulin pens, and insulin pumps. In addition to this, various other physiological minimally invasive or noninvasive ways for delivering insulin are oral, buccal, nasal, peritoneal and transdermal.
Global insulin market has witnessed strong growth owing to various underlying favorable dynamics. Growth of the market is propelled by increasing incidences of diabetes, rise in geriatric population, growing the obese population, propagation of Diabetes management awareness and government impetus. However, the market faces several challenges such as high cost of insulin pumps, insurance coverage issues, regulatory pressure and technological issues.
The report “Global Insulin Delivery Device Market – (By Type-Vials & Syringes, Insulin Pens & Insulin Pumps; By Region- North America, Europe & Asia Pacific) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global insulin delivery devices market with coverage on major market segments such as Vials & Syringes, Insulin Pens & Insulin Pumps. Future forecasts of insulin delivery devices market overall and across various sub-segments till 2025 is provided in the report. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global insulin delivery devices market include Novo Nordisk, Sanofi Aventis, Eli Lilly and Company, Merck & Co., among others. These players are profiled herein based on attributes such as business overview, product segments, and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in the global insulin delivery devices market.
Key Factors Impacting Market Growth:
- Increase the incidences of diabetes
- The rise in geriatric population
- Growing obese population
North America, Western Europe, and Asia Pacific by region are estimated to dominate the insulin delivery devices market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for insulin delivery devices market during the forecast period.
The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for insulin delivery devices market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for insulin delivery devices market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for insulin delivery devices during the forecast period.
Companies Covered: Novo Nordisk, Sanofi Aventis, Eli Lilly and Company, Merck & Co.
- Insulin Pen
- Insulin Vial
- Syringes and Insulin Pumps
- North America
- Asia Pacific
- Rest of the World
Reasons To Buy This Report:
- Market size estimation of the global insulin delivery devices market on a regional and global basis
- The unique research design for market size estimation and forecast
- Profiling of major companies operating in the market with key developments
- Broad scope to cover all the possible segments helping every stakeholder in the market
We provide customization of the study to meet specific requirements:
- By Segment
- By Sub-segment
- By Region/Country
For more information, contact: [email protected]